Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

GeoVax Labs (GOVX) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for GeoVax Labs (GOVX) over the last 16 years, with Q3 2025 value amounting to $20.3 million.

  • GeoVax Labs' Shares Outstanding (Weighted Average) rose 21675.01% to $20.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.3 million, marking a year-over-year increase of 21675.01%. This contributed to the annual value of $5.2 million for FY2024, which is 18542.83% up from last year.
  • As of Q3 2025, GeoVax Labs' Shares Outstanding (Weighted Average) stood at $20.3 million, which was up 21675.01% from $15.4 million recorded in Q2 2025.
  • Over the past 5 years, GeoVax Labs' Shares Outstanding (Weighted Average) peaked at $23.5 million during Q3 2022, and registered a low of $1.1 million during Q4 2022.
  • For the 5-year period, GeoVax Labs' Shares Outstanding (Weighted Average) averaged around $7.4 million, with its median value being $6.1 million (2021).
  • As far as peak fluctuations go, GeoVax Labs' Shares Outstanding (Weighted Average) surged by 217481.73% in 2021, and later tumbled by 9245.75% in 2023.
  • GeoVax Labs' Shares Outstanding (Weighted Average) (Quarter) stood at $6.1 million in 2021, then tumbled by 81.45% to $1.1 million in 2022, then surged by 60.6% to $1.8 million in 2023, then surged by 185.43% to $5.2 million in 2024, then skyrocketed by 291.11% to $20.3 million in 2025.
  • Its last three reported values are $20.3 million in Q3 2025, $15.4 million for Q2 2025, and $12.0 million during Q1 2025.